 | • レポートコード：MRC2012B0127 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、眼瞼炎の世界市場を広く調査・分析し、今後の市場展望をまとめております。眼瞼炎の種類別市場規模（抗生物質、ステロイド、その他）、用途別市場規模（単剤療法、併用薬物療法）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Bausch Health、LABORATORIES THEA、Allergan、Scope Ophthalmics、Novartis、NovaBay Pharmaceuticals、Akorn、 ・地域別グローバル市場分析 2015年-2020年 ・眼瞼炎の北米市場（アメリカ、カナダ、メキシコ） ・眼瞼炎のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・眼瞼炎のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・眼瞼炎の南米市場（ブラジル、アルゼンチン） ・眼瞼炎の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：抗生物質、ステロイド、その他 ・用途別分析：単剤療法、併用薬物療法 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Blepharitis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Blepharitis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.1%% in the forecast period of 2020 to 2025 and will expected to reach USD 1675 million by 2025, from USD 1423.9 million in 2019.
Market segmentation
Blepharitis market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Blepharitis market has been segmented into:
Antibiotics
Steroids
Other
By Application, Blepharitis has been segmented into:
Monotherapy
Combination Drug Therapy
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Blepharitis market presented in the report. This section sheds light on the sales growth of different regional and country-level Blepharitis markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Blepharitis market.
The report offers in-depth assessment of the growth and other aspects of the Blepharitis market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Blepharitis Market Share Analysis
Blepharitis competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Blepharitis sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Blepharitis sales, revenue and market share for each player covered in this report.
The major players covered in Blepharitis are:
Bausch Health
LABORATORIES THEA
Allergan
Scope Ophthalmics
Novartis
NovaBay Pharmaceuticals
Akorn
Among other players domestic and global, Blepharitis market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Blepharitis Market Overview
1.1 Product Overview and Scope of Blepharitis
1.2 Classification of Blepharitis by Type
1.2.1 Global Blepharitis Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Blepharitis Revenue Market Share by Type in 2019
1.2.3 Antibiotics
1.2.4 Steroids
1.2.5 Other
1.3 Global Blepharitis Market by Application
1.3.1 Overview: Global Blepharitis Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Monotherapy
1.3.3 Combination Drug Therapy
1.4 Global Blepharitis Market by Regions
1.4.1 Global Blepharitis Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Blepharitis (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Blepharitis Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Blepharitis Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Blepharitis Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Blepharitis Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Blepharitis Status and Prospect (2015-2025)
2 Company Profiles
2.1 Bausch Health
2.1.1 Bausch Health Details
2.1.2 Bausch Health Major Business
2.1.3 Bausch Health SWOT Analysis
2.1.4 Bausch Health Product and Services
2.1.5 Bausch Health Blepharitis Revenue, Gross Margin and Market Share (2018-2019)
2.2 LABORATORIES THEA
2.2.1 LABORATORIES THEA Details
2.2.2 LABORATORIES THEA Major Business
2.2.3 LABORATORIES THEA SWOT Analysis
2.2.4 LABORATORIES THEA Product and Services
2.2.5 LABORATORIES THEA Blepharitis Revenue, Gross Margin and Market Share (2018-2019)
2.3 Allergan
2.3.1 Allergan Details
2.3.2 Allergan Major Business
2.3.3 Allergan SWOT Analysis
2.3.4 Allergan Product and Services
2.3.5 Allergan Blepharitis Revenue, Gross Margin and Market Share (2018-2019)
2.4 Scope Ophthalmics
2.4.1 Scope Ophthalmics Details
2.4.2 Scope Ophthalmics Major Business
2.4.3 Scope Ophthalmics SWOT Analysis
2.4.4 Scope Ophthalmics Product and Services
2.4.5 Scope Ophthalmics Blepharitis Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis SWOT Analysis
2.5.4 Novartis Product and Services
2.5.5 Novartis Blepharitis Revenue, Gross Margin and Market Share (2018-2019)
2.6 NovaBay Pharmaceuticals
2.6.1 NovaBay Pharmaceuticals Details
2.6.2 NovaBay Pharmaceuticals Major Business
2.6.3 NovaBay Pharmaceuticals Product and Services
2.6.4 NovaBay Pharmaceuticals Blepharitis Revenue, Gross Margin and Market Share (2018-2019)
2.7 Akorn
2.7.1 Akorn Details
2.7.2 Akorn Major Business
2.7.3 Akorn Product and Services
2.7.4 Akorn Blepharitis Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Blepharitis Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Blepharitis Players Market Share
3.2.2 Top 10 Blepharitis Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Blepharitis Revenue and Market Share by Regions
4.2 North America Blepharitis Revenue and Growth Rate (2015-2020)
4.3 Europe Blepharitis Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Blepharitis Revenue and Growth Rate (2015-2020)
4.5 South America Blepharitis Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Blepharitis Revenue and Growth Rate (2015-2020)
5 North America Blepharitis Revenue by Countries
5.1 North America Blepharitis Revenue by Countries (2015-2020)
5.2 USA Blepharitis Revenue and Growth Rate (2015-2020)
5.3 Canada Blepharitis Revenue and Growth Rate (2015-2020)
5.4 Mexico Blepharitis Revenue and Growth Rate (2015-2020)
6 Europe Blepharitis Revenue by Countries
6.1 Europe Blepharitis Revenue by Countries (2015-2020)
6.2 Germany Blepharitis Revenue and Growth Rate (2015-2020)
6.3 UK Blepharitis Revenue and Growth Rate (2015-2020)
6.4 France Blepharitis Revenue and Growth Rate (2015-2020)
6.5 Russia Blepharitis Revenue and Growth Rate (2015-2020)
6.6 Italy Blepharitis Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Blepharitis Revenue by Countries
7.1 Asia-Pacific Blepharitis Revenue by Countries (2015-2020)
7.2 China Blepharitis Revenue and Growth Rate (2015-2020)
7.3 Japan Blepharitis Revenue and Growth Rate (2015-2020)
7.4 Korea Blepharitis Revenue and Growth Rate (2015-2020)
7.5 India Blepharitis Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Blepharitis Revenue and Growth Rate (2015-2020)
8 South America Blepharitis Revenue by Countries
8.1 South America Blepharitis Revenue by Countries (2015-2020)
8.2 Brazil Blepharitis Revenue and Growth Rate (2015-2020)
8.3 Argentina Blepharitis Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Blepharitis by Countries
9.1 Middle East & Africa Blepharitis Revenue by Countries (2015-2020)
9.2 Saudi Arabia Blepharitis Revenue and Growth Rate (2015-2020)
9.3 UAE Blepharitis Revenue and Growth Rate (2015-2020)
9.4 Egypt Blepharitis Revenue and Growth Rate (2015-2020)
9.5 South Africa Blepharitis Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Blepharitis Revenue and Market Share by Type (2015-2020)
10.2 Global Blepharitis Market Forecast by Type (2019-2024)
10.3 Antibiotics Revenue Growth Rate (2015-2025)
10.4 Steroids Revenue Growth Rate (2015-2025)
10.5 Other Revenue Growth Rate (2015-2025)
11 Global Blepharitis Market Segment by Application
11.1 Global Blepharitis Revenue Market Share by Application (2015-2020)
11.2 Blepharitis Market Forecast by Application (2019-2024)
11.3 Monotherapy Revenue Growth (2015-2020)
11.4 Combination Drug Therapy Revenue Growth (2015-2020)
12 Global Blepharitis Market Size Forecast (2021-2025)
12.1 Global Blepharitis Market Size Forecast (2021-2025)
12.2 Global Blepharitis Market Forecast by Regions (2021-2025)
12.3 North America Blepharitis Revenue Market Forecast (2021-2025)
12.4 Europe Blepharitis Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Blepharitis Revenue Market Forecast (2021-2025)
12.6 South America Blepharitis Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Blepharitis Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Blepharitis Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Blepharitis by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Blepharitis Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Blepharitis Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Blepharitis Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Bausch Health Corporate Information, Location and Competitors
Table 7. Bausch Health Blepharitis Major Business
Table 8. Bausch Health Blepharitis Total Revenue (USD Million) (2017-2018)
Table 9. Bausch Health SWOT Analysis
Table 10. Bausch Health Blepharitis Product and Solutions
Table 11. Bausch Health Blepharitis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. LABORATORIES THEA Corporate Information, Location and Competitors
Table 13. LABORATORIES THEA Blepharitis Major Business
Table 14. LABORATORIES THEA Blepharitis Total Revenue (USD Million) (2018-2019)
Table 15. LABORATORIES THEA SWOT Analysis
Table 16. LABORATORIES THEA Blepharitis Product and Solutions
Table 17. LABORATORIES THEA Blepharitis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Allergan Corporate Information, Location and Competitors
Table 19. Allergan Blepharitis Major Business
Table 20. Allergan Blepharitis Total Revenue (USD Million) (2017-2018)
Table 21. Allergan SWOT Analysis
Table 22. Allergan Blepharitis Product and Solutions
Table 23. Allergan Blepharitis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Scope Ophthalmics Corporate Information, Location and Competitors
Table 25. Scope Ophthalmics Blepharitis Major Business
Table 26. Scope Ophthalmics Blepharitis Total Revenue (USD Million) (2017-2018)
Table 27. Scope Ophthalmics SWOT Analysis
Table 28. Scope Ophthalmics Blepharitis Product and Solutions
Table 29. Scope Ophthalmics Blepharitis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Novartis Corporate Information, Location and Competitors
Table 31. Novartis Blepharitis Major Business
Table 32. Novartis Blepharitis Total Revenue (USD Million) (2017-2018)
Table 33. Novartis SWOT Analysis
Table 34. Novartis Blepharitis Product and Solutions
Table 35. Novartis Blepharitis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. NovaBay Pharmaceuticals Corporate Information, Location and Competitors
Table 37. NovaBay Pharmaceuticals Blepharitis Major Business
Table 38. NovaBay Pharmaceuticals Blepharitis Total Revenue (USD Million) (2017-2018)
Table 39. NovaBay Pharmaceuticals SWOT Analysis
Table 40. NovaBay Pharmaceuticals Blepharitis Product and Solutions
Table 41. NovaBay Pharmaceuticals Blepharitis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Akorn Corporate Information, Location and Competitors
Table 43. Akorn Blepharitis Major Business
Table 44. Akorn Blepharitis Total Revenue (USD Million) (2017-2018)
Table 45. Akorn SWOT Analysis
Table 46. Akorn Blepharitis Product and Solutions
Table 47. Akorn Blepharitis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Global Blepharitis Revenue (Million USD) by Players (2015-2020)
Table 49. Global Blepharitis Revenue Share by Players (2015-2020)
Table 50. Global Blepharitis Revenue (Million USD) by Regions (2015-2020)
Table 51. Global Blepharitis Revenue Market Share by Regions (2015-2020)
Table 52. North America Blepharitis Revenue by Countries (2015-2020)
Table 53. North America Blepharitis Revenue Market Share by Countries (2015-2020)
Table 54. Europe Blepharitis Revenue (Million USD) by Countries (2015-2020)
Table 55. Asia-Pacific Blepharitis Revenue (Million USD) by Countries (2015-2020)
Table 56. South America Blepharitis Revenue by Countries (2015-2020)
Table 57. South America Blepharitis Revenue Market Share by Countries (2015-2020)
Table 58. Middle East and Africa Blepharitis Revenue (Million USD) by Countries (2015-2020)
Table 59. Middle East and Africa Blepharitis Revenue Market Share by Countries (2015-2020)
Table 60. Global Blepharitis Revenue (Million USD) by Type (2015-2020)
Table 61. Global Blepharitis Revenue Share by Type (2015-2020)
Table 62. Global Blepharitis Revenue Forecast by Type (2021-2025)
Table 63. Global Blepharitis Revenue by Application (2015-2020)
Table 64. Global Blepharitis Revenue Share by Application (2015-2020)
Table 65. Global Blepharitis Revenue Forecast by Application (2021-2025)
Table 66. Global Blepharitis Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Blepharitis Picture
Figure 2. Global Blepharitis Revenue Market Share by Type in 2019
Figure 3. Antibiotics Picture
Figure 4. Steroids Picture
Figure 5. Other Picture
Figure 6. Blepharitis Revenue Market Share by Application in 2019
Figure 7. Monotherapy Picture
Figure 8. Combination Drug Therapy Picture
Figure 9. Global Blepharitis Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Blepharitis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Blepharitis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Blepharitis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Blepharitis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Blepharitis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Blepharitis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Blepharitis Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Blepharitis Revenue Market Share in 2019
Figure 18. Global Top 10 Players Blepharitis Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Blepharitis Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Blepharitis Revenue Market Share by Regions (2015-2020)
Figure 22. Global Blepharitis Revenue Market Share by Regions in 2018
Figure 23. North America Blepharitis Revenue and Growth Rate (2015-2020)
Figure 24. Europe Blepharitis Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Blepharitis Revenue and Growth Rate (2015-2020)
Figure 26. South America Blepharitis Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Blepharitis Revenue and Growth Rate (2015-2020)
Figure 28. North America Blepharitis Revenue Market Share by Countries (2015-2020)
Figure 29. North America Blepharitis Revenue Market Share by Countries in 2019
Figure 30. USA Blepharitis Revenue and Growth Rate (2015-2020)
Figure 31. Canada Blepharitis Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Blepharitis Revenue and Growth Rate (2015-2020)
Figure 33. Europe Blepharitis Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Blepharitis Revenue Market Share by Countries in 2019
Figure 35. Germany Blepharitis Revenue and Growth Rate (2015-2020)
Figure 36. UK Blepharitis Revenue and Growth Rate (2015-2020)
Figure 37. France Blepharitis Revenue and Growth Rate (2015-2020)
Figure 38. Russia Blepharitis Revenue and Growth Rate (2015-2020)
Figure 39. Italy Blepharitis Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Blepharitis Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Blepharitis Revenue Market Share by Countries in 2019
Figure 42. China Blepharitis Revenue and Growth Rate (2015-2020)
Figure 43. Japan Blepharitis Revenue and Growth Rate (2015-2020)
Figure 44. Korea Blepharitis Revenue and Growth Rate (2015-2020)
Figure 45. India Blepharitis Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Blepharitis Revenue and Growth Rate (2015-2020)
Figure 47. South America Blepharitis Revenue Market Share by Countries (2015-2020)
Figure 48. South America Blepharitis Revenue Market Share by Countries in 2019
Figure 49. Brazil Blepharitis Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Blepharitis Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Blepharitis Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Blepharitis Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Blepharitis Revenue and Growth Rate (2015-2020)
Figure 54. UAE Blepharitis Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Blepharitis Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Blepharitis Revenue and Growth Rate (2015-2020)
Figure 57. Global Blepharitis Revenue Share by Type (2015-2020)
Figure 58. Global Blepharitis Revenue Share by Type in 2019
Figure 59. Global Blepharitis Market Share Forecast by Type (2021-2025)
Figure 60. Global Antibiotics Revenue Growth Rate (2015-2020)
Figure 61. Global Steroids Revenue Growth Rate (2015-2020)
Figure 62. Global Other Revenue Growth Rate (2015-2020)
Figure 63. Global Blepharitis Revenue Share by Application (2015-2020)
Figure 64. Global Blepharitis Revenue Share by Application in 2019
Figure 65. Global Blepharitis Market Share Forecast by Application (2021-2025)
Figure 66. Global Monotherapy Revenue Growth Rate (2015-2020)
Figure 67. Global Combination Drug Therapy Revenue Growth Rate (2015-2020)
Figure 68. Global Blepharitis Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Blepharitis Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Blepharitis Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Blepharitis Revenue Market Forecast (2021-2025)
Figure 72. Europe Blepharitis Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Blepharitis Revenue Market Forecast (2021-2025)
Figure 74. South America Blepharitis Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Blepharitis Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
眼瞼炎の世界市場（～2026年） Blepharitis is a chronic condition that is caused by chronic inflammation of the eyelid. It is a common eye disorder that is caused either by bacterial infection or skin condition (dandruff on scalp or acne rosacea). This is not a contagious disease condition and generally does not cause a permanent…- 美学併用療法の世界市場（～2026年） Combination treatment in aesthetic market consists of various treatment approaches such as neuromodulators, derma fillers, topical therapies, intense pulsed light photo rejuvenation, laser therapies, radiofrequency-based therapies and ultra-radiofrequency-based therapies. The market is expected to w…
- 併用抗体療法の世界市場（～2026年） Combination antibody therapy is receiving higher recognition from the oncological branch of medical science research. This is primarily due to the growing use of combination therapy over single drug treatments such as radiation or chemotherapy. In addition, companies that manufacture combination ant…
- 加齢黄斑変性症（AMD）遺伝子治療の世界市場（～2026年） Macular degeneration is a condition in which, macula, a part of the retina, gets damaged or deteriorated. This condition usually affects individuals who are aged 50 years and above and therefore, it is called age-related macular degeneration (AMD). AMD is the leading cause of vision loss and is dire…
- 変形性関節症における幹細胞治療の世界市場（～2026年） Osteoarthritis is one of the chronic conditions for joints which results in the breakdown and eventual loss of the cartilage of one or more joints. This can affect joints including hips, lower back, neck, small joints of the fingers, and the base of the thumb and big toe. The expected growth is beca…